A metabolomic investigation of the effects of vitamin E supplementation in humans

Nutrition & Metabolism

John K Lodge¹  Max Wong¹ 

[1] Faculty of Health and Medical Sciences, University of Surrey, Guildford, Surrey, GU2 7XH, UK

关键词: Lysophospholipids;    Vitamin E;    LC/MS;    Metabolite profiling;   

Others  :  811591
DOI  :  10.1186/1743-7075-9-110

 received in 2012-10-17, accepted in 2012-12-15,  发布年份 2012

【 摘 要 】

Background

Vitamin E is a nutrient with both antioxidant and non-antioxidant activities and has been shown to modulate the function of a number of cell types in vitro and in human studies. However studies have also shown vitamin E to have detrimental interactions and therefore it is important to establish the extent to which this nutrient influences metabolism. Metabolomics can potentially identify nutrient-metabolism interactions and therefore the aim of this study was to use a non-targeted metabolomic approach to identify changes to the plasma metabolome following vitamin E supplementation in humans.

Methods

A relatively homogenous healthy adult male population (n = 10) provided a fasting blood sample immediately before and after a 4-week vitamin E supplementation regime (400 mg/d of RRR-α-tocopheryl acetate)) on top of their habitual diet. Plasma samples were analysed for vitamin E and clinical markers. Plasma underwent non-targeted metabolite profiling using liquid chromatography/mass spectroscopy and data was processed using multivariate statistical analysis.

Results

Plasma vitamin E concentrations were significantly increased following supplementation (p < 0.001). A partial least squares-discriminant analysis (PLS-DA) model was able to discriminate between samples taken pre and post vitamin E supplementation (goodness of fit R²Y = 0.82, predictive ability Q² = 0.50). Variable influence on projection and PLS-DA loadings highlighted a number of discriminating ions that were confirmed as discriminatory through pairwise analysis. From database searches and comparison with standards these metabolites included a number of lysophosphatidylcholine species (16:0, 18:0, 18:1, 18:2, 20:3 and 22:6) that were increased in intensity post supplementation by varying degrees from 4% to 29% with the greatest changes found for lysoPC 22:6 and 20:3.

Conclusions

Although a small scale study, these results potentially indicate that vitamin E supplementation influences phospholipid metabolism and induces lysoPC generation; a general pro-inflammatory response. Moreover the study identifies novel areas of vitamin E interactions and highlights the potential of metabolomics for elucidating interactions between nutrients and metabolic pathways in nutritional research.

【 授权许可】

   
2012 Wong and Lodge; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Rezzi S, Ramadan Z, Fay LB, Kochhar S: Nutritional metabonomics: applications and perspectives. J Proteome Res 2007, 6:513-525.
• [2]Burton GW, Traber MG: Vitamin E: antioxidant activity, biokinetics and bioavailability. Annu Rev Nutr 1990, 10:357-382.
• [3]Rimbach G, Minihane AM, Majewicz J, Fischer A, Pallauf J, Virgli F, Weinberg PD: Regulation of cell signalling by vitamin E. Proc Nutr Soc 2002, 61:415-425.
• [4]Azzi A, Breyer I, Feher M, Pastori M, Ricciarelli R, Spycher S, Staffieri M, Stocker A, Zimmer S, Zingg JM: Specific cellular responses to alpha-tocopherol. J Nutr 2000, 130:1649-1652.
• [5]Rimbach G, Moehring J, Huebbe P, Lodge JK: Gene-regulatory activity of alpha-tocopherol. Molecules 2010, 15:1746-1761.
• [6]Azzi A, Gysin R, Kempna P, Munteanu A, Villacorta L, Visarius T, Zingg JM: Regulation of gene expression by alpha-tocopherol. Biol Chem 2004, 385:585-591.
• [7]Birringer M, Kuhlow D, Pfluger PT, Landes N, Schulz TJ, Glaubitz M, Florian S, Pfeiffer A, Schuelke M, Brigelius-Flohe R, Ristow M: Improved glucose metabolism in mice lacking alpha-tocopherol transfer protein. Eur J Nutr 2007, 46:397-405.
• [8]Williams JC, Forster LA, Tull SP, Ferns GA: Effects of vitamin E on human platelet and mononuclear cell responses in vitro. Int J Exp Pathol 1999, 80:227-234.
• [9]Devaraj S, Li D, Jialal I: The effects of alpha-tocopherol supplementation on monocyte function. Decreased lipid oxidation, interleukin 1 beta secretion and monocyte adhesion to endothelium. J Clin Investig 1996, 98:756-763.
• [10]Devaraj S, Tang R, Adams-Huet B, Harris A, Seenivasan T, de Lemos JA, Jialal I: Effect of high-dose alpha-tocopherol supplementation on biomarkers of oxidative stress and inflammation and carotid atherosclerosis in patients with coronary artery disease. Am J Clin Nutr 2007, 86:1392-1398.
• [11]Miller ER 3rd, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E: Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 2005, 142:37-46.
• [12]Brigelius-Flohe R: Adverse effects of vitamin E by induction of drug metabolism. Genes Nutr 2007, 2:249-256.
• [13]Gibney MJ, Walsh M, Brennan L, Roche HM, German B, van Ommen B: Metabolomics in human nutrition: opportunities and challenges. Am J Clin Nutr 2005, 82:497-503.
• [14]Lodge JK: Symposium 2: modern approaches to nutritional research challenges: targeted and non-targeted approaches for metabolite profiling in nutritional research. Proc Nutr Soc 2010, 69:95-102.
• [15]Fave G, Beckmann ME, Draper JH, Mathers JC: Measurement of dietary exposure: a challenging problem which may be overcome thanks to metabolomics? Genes Nutr 2009, 4:135-141.
• [16]Primrose S, Draper J, Elsom R, Kirkpatrick V, Mathers JC, Seal C, Beckmann M, Haldar S, Beattie JH, Lodge JK, et al.: Metabolomics and human nutrition. Br J Nutr 2011, 105:1277-1283.
• [17]Stella C, Beckwith-Hall B, Cloarec O, Holmes E, Lindon JC, Powell J, van der Ouderaa F, Bingham S, Cross AJ, Nicholson JK: Susceptibility of human metabolic phenotypes to dietary modulation. J Proteome Res 2006, 5:2780-2788.
• [18]Zhao X, Peter A, Fritsche J, Elcnerova M, Fritsche A, Haring HU, Schleicher ED, Xu G, Lehmann R: Changes of the plasma metabolome during an oral glucose tolerance test: is there more than glucose to look at? Am J Physiol Endocrinol Metab 2009, 296:E384-393.
• [19]Cho JY, Kang DW, Ma X, Ahn SH, Krausz KW, Luecke H, Idle JR, Gonzalez FJ: Metabolomics reveals a novel vitamin E metabolite and attenuated vitamin E metabolism upon PXR activation. J Lipid Res 2009, 50:924-937.
• [20]Johnson CH, Slanar O, Krausz KW, Kang DW, Patterson AD, Kim JH, Luecke H, Gonzalez FJ, Idle JR: Novel metabolites and roles for alpha-tocopherol in humans and mice discovered by mass spectrometry-based metabolomics. Am J Clin Nutr 2012, 96:818-830.
• [21]Griffin JL, Muller D, Woograsingh R, Jowatt V, Hindmarsh A, Nicholson JK, Martin JE: Vitamin E deficiency and metabolic deficits in neuronal ceroid lipofuscinosis described by bioinformatics. Physiol Genomics 2002, 11:195-203.
• [22]Moazzami AA, Andersson R, Kamal-Eldin A: Changes in the metabolic profile of rat liver after alpha-tocopherol deficiency as revealed by metabolomics analysis. NMR Biomed 2011, 24:499-505.
• [23]Cheng J, Joyce A, Yates K, Aouizerat B, Sanyal AJ: Metabolomic profiling to identify predictors of response to vitamin E for Non-Alcoholic Steatohepatitis (NASH). PLoS One 2012, 7:e44106.
• [24]Podda M, Weber C, Traber MG, Packer L: Simultaneous determination of tissue tocopherols, tocotrienols, ubiquinols and ubiquinones. J Lipid Res 1996, 37:893-901.
• [25]Proteggente AR, Rota C, Majewicz J, Rimbach G, Minihane AM, Kraemer K, Lodge JK: Cigarette smokers differ in their handling of natural (RRR) and synthetic (all rac) alpha-tocopherol: a biokinetic study in apoE4 male subjects. Free Radic Biol Med 2006, 40:2080-2091.
• [26]Traber MG, Rader D, Acuff RV, Ramakrishnan R, Brewer HB, Kayden HJ: Vitamin E dose–response studies in humans with use of deuterated RRR-alpha-tocopherol. Am J Clin Nutr 1998, 68:847-853.
• [27]Kemsley EK, Le Gall G, Dainty JR, Watson AD, Harvey LJ, Tapp HS, Colquhoun IJ: Multivariate techniques and their application in nutrition: a metabolomics case study. Br J Nutr 2007, 98:1-14.
• [28]Han X, Gross RW: Shotgun lipidomics: electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples. Mass Spectrom Rev 2005, 24:367-412.
• [29]Yang J, Zhao X, Liu X, Wang C, Gao P, Wang J, Li L, Gu J, Yang S, Xu G: High performance liquid chromatography-mass spectrometry for metabonomics: potential biomarkers for acute deterioration of liver function in chronic hepatitis B. J Proteome Res 2006, 5:554-561.
• [30]Xia YQ, Jemal M: Phospholipids in liquid chromatography/mass spectrometry bioanalysis: comparison of three tandem mass spectrometric techniques for monitoring plasma phospholipids, the effect of mobile phase composition on phospholipids elution and the association of phospholipids with matrix effects. Rapid Commun Mass Spectrom 2009, 23:2125-2138.
• [31]Leonard SW, Paterson E, Atkinson JK, Ramakrishnan R, Cross CE, Traber MG: Studies in humans using deuterium-labeled alpha- and gamma-tocopherols demonstrate faster plasma gamma-tocopherol disappearance and greater gamma-metabolite production. Free Radic Biol Med 2005, 38:857-866.
• [32]Kougias P, Chai H, Lin PH, Lumsden AB, Yao Q, Chen C: Lysophosphatidylcholine and secretory phospholipase A2 in vascular disease: mediators of endothelial dysfunction and atherosclerosis. Med Sci Monit 2006, 12:RA5-16.
• [33]Ojala PJ, Hirvonen TE, Hermansson M, Somerharju P, Parkkinen J: Acyl chain-dependent effect of lysophosphatidylcholine on human neutrophils. J Leukoc Biol 2007, 82:1501-1509.
• [34]Murohara T, Ikeda H, Katoh A, Takajo Y, Otsuka Y, Haramaki N, Imaizumi T: Vitamin E inhibits lysophosphatidylcholine-induced endothelial dysfunction and platelet activation. Antioxid Redox Signal 2002, 4:791-798.
• [35]Kohno M, Yokokawa K, Yasunari K, Minami M, Kano H, Hanehira T, Yoshikawa J: Induction by lysophosphatidylcholine, a major phospholipid component of atherogenic lipoproteins, of human coronary artery smooth muscle cell migration. Circulation 1998, 98:353-359.
• [36]Feldman C, Anderson R, Theron AJ, Steel HC, van Rensburg CE, Cole PJ, Wilson R: Vitamin E attenuates the injurious effects of bioactive phospholipids on human ciliated epithelium in vitro. Eur Respir J 2001, 18:122-129.
• [37]Wu D, Liu L, Meydani M, Meydani SN: Vitamin E increases production of vasodilator prostanoids in human aortic endothelial cells through opposing effects on cyclooxygenase-2 and phospholipase A2. J Nutr 2005, 135:1847-1853.
• [38]Yea K, Kim J, Yoon JH, Kwon T, Kim JH, Lee BD, Lee HJ, Lee SJ, Kim JI, Lee TG, et al.: Lysophosphatidylcholine activates adipocyte glucose uptake and lowers blood glucose levels in murine models of diabetes. J Biol Chem 2009, 284:33833-33840.
• [39]Soga T, Ohishi T, Matsui T, Saito T, Matsumoto M, Takasaki J, Matsumoto S, Kamohara M, Hiyama H, Yoshida S, et al.: Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor. Biochem Biophys Res Commun 2005, 326:744-751.
• [40]Wang-Sattler R, Yu Z, Herder C, Messias AC, Floegel A, He Y, Heim K, Campillos M, Holzapfel C, Thorand B, et al.: Novel biomarkers for pre-diabetes identified by metabolomics. Mol Syst Biol 2012, 8:615.
• [41]Zingg JM: Modulation of signal transduction by vitamin E. Mol Aspects Med 2007, 28:481-506.
• [42]Chan AC, Wagner M, Kennedy C, Chen E, Lanuville O, Mezl VA, Tran K, Choy PC: Vitamin E up-regulates arachidonic acid release and phospholipase A2 in megakaryocytes. Mol Cell Biochem 1998, 189:153-159.
• [43]Kwag OG, Kim SO, Choi JH, Rhee IK, Choi MS, Rhee SJ: Vitamin E improves microsomal phospholipase A2 activity and the arachidonic acid cascade in kidney of diabetic rats. J Nutr 2001, 131:1297-1301.
• [44]Chandra V, Jasti J, Kaur P, Betzel C, Srinivasan A, Singh TP: First structural evidence of a specific inhibition of phospholipase A2 by alpha-tocopherol (vitamin E) and its implications in inflammation: crystal structure of the complex formed between phospholipase A2 and alpha-tocopherol at 1.8 A resolution. J Mol Biol 2002, 320:215-222.
• [45]Rhee SJ, Jeong YC, Choi JH: Effects of vitamin E on phospholipase A2 activity and oxidative damage to the liver in streptozotocin-induced diabetic rats. Ann Nutr Metab 2005, 49:392-396.
• [46]Zingg JM, Azzi A: Non-antioxidant activities of vitamin E. Curr Med Chem 2004, 11:1113-1133.
• [47]Silbert PL, Leong LL, Sturm MJ, Strophair J, Taylor RR: Short term vitamin E supplementation has no effect on platelet function, plasma phospholipase A2 and lyso-PAF in male volunteers. Clin Exp Pharmacol Physiol 1990, 17:645-651.
• [48]Wang X, Quinn PJ: Vitamin E and its function in membranes. Prog Lipid Res 1999, 38:309-336.
• [49]Fuchs B, Schiller J, Wagner U, Hantzschel H, Arnold K: The phosphatidylcholine/lysophosphatidylcholine ratio in human plasma is an indicator of the severity of rheumatoid arthritis: investigations by 31P NMR and MALDI-TOF MS. Clin Biochem 2005, 38:925-933.
• [50]Iwase M, Sonoki K, Sasaki N, Ohdo S, Higuchi S, Hattori H, Iida M: Lysophosphatidylcholine contents in plasma LDL in patients with type 2 diabetes mellitus: relation with lipoprotein-associated phospholipase A2 and effects of simvastatin treatment. Atherosclerosis 2008, 196:931-936.
• [51]Pietilainen KH, Sysi-Aho M, Rissanen A, Seppanen-Laakso T, Yki-Jarvinen H, Kaprio J, Oresic M: Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects - a monozygotic twin study. PLoS One 2007, 2:e218.
• [52]Zhao Z, Xiao Y, Elson P, Tan H, Plummer SJ, Berk M, Aung PP, Lavery IC, Achkar JP, Li L, et al.: Plasma lysophosphatidylcholine levels: potential biomarkers for colorectal cancer. J Clin Oncol 2007, 25:2696-2701.
• [53]Drobnik W, Liebisch G, Audebert FX, Frohlich D, Gluck T, Vogel P, Rothe G, Schmitz G: Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients. J Lipid Res 2003, 44:754-761.